Joseph Wilson
Joseph has recently finished medical school and is currently working in the Dunachie group exploring SARS-CoV-2 breakthrough infection. He has previously worked in the oncology department examining blockade of the DNA damage response in hypoxic tumours. Joseph's wider interest is the interface between host and pathogen, and the extent to which genomics can explain why two seemingly matched individuals have such different clinical courses in response to the same pathogen. Later this year he will be moving to King's College Hospital, London.